| Literature DB >> 33572915 |
Beatriz Leão1,2, Xiaogang Wen3,4, Henrique O Duarte2,4, Irene Gullo1,2,4,5,6, Gilza Gonçalves4, Patrícia Pontes4,5, Claudia Castelli7, Francisca Diniz2,4,8, Stefan Mereiter2,4, Joana Gomes2,4, Fátima Carneiro1,2,4,5,6, Celso A Reis1,2,4,6,8.
Abstract
Microsatellite instability (MSI) is a molecular phenotype due to a deficient DNA mismatch repair (dMMR). In colorectal cancer (CRC), dMMR/MSI is associated with several clinical and histopathological features, influences prognosis, and is a predictive factor of response to therapy. In daily practice, dMMR/MSI profiles are identified by immunohistochemistry and/or multiplex PCR. The Thomsen-Friedenreich (TF) antigen was previously found to be a potential single marker to identify MSI-high gastric cancers. Therefore, in this study, we aimed to disclose a possible association between TF expression and MSI status in CRC. Furthermore, we evaluated the relationship between TF expression and other clinicopathological features, including patient survival. We evaluated the expression of the TF antigen in a cohort of 25 MSI-high and 71 microsatellite stable (MSS) CRCs. No association was observed between the expression of the TF antigen and MSI-high status in CRC. The survival analysis revealed that patients with MSI-high CRC showed improved survival when the TF antigen was expressed. This finding holds promise as it indicates the potential use of the TF antigen as a biomarker of better prognosis in MSI-high CRCs that should be validated in an independent and larger CRC cohort.Entities:
Keywords: O-glycan; Thomsen–Friedenreich antigen; colorectal cancer; glycosylation; microsatellite instability
Mesh:
Substances:
Year: 2021 PMID: 33572915 PMCID: PMC7866256 DOI: 10.3390/ijms22031340
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923